Immunovant (IMVT)
(Delayed Data from NSDQ)
$15.71 USD
-0.37 (-2.30%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $15.46 -0.25 (-1.59%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Immunovant, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
IMVT 15.71 -0.37(-2.30%)
Will IMVT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IMVT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IMVT
All You Need to Know About Immunovant (IMVT) Rating Upgrade to Buy
Wall Street Analysts See a 137.68% Upside in Immunovant (IMVT): Can the Stock Really Move This High?
IMVT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Immunovant (IMVT) Upgraded to Buy: What Does It Mean for the Stock?
IMVT Q4 Loss Narrower Than Expected, Stock Up, Pipeline in Focus
IMVT Unlikely to Pursue Batoclimab for MG & CIDP Despite Success
Other News for IMVT
Deep Track Capital, LP Increases Stake in Tarsus Pharmaceuticals Inc
Immunovant (IMVT) Price Target Raised to $18 by UBS Analyst
Immunovant price target raised by $1 at UBS, here's why
UBS Raises Price Target for Immunovant (IMVT) to $18.00 | IMVT Stock News
IMVT Stock Offering Managed by Morgan Stanley Sees Wide Price Range | IMVT Stock News